Atlas Trials

BioVersys AG

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch BioVersys AG

RecordFirmDate
Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex (NCT07431307)BioVersys AG2026-07-01
Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis (NCT07350174)BioVersys AG2026-03-30
Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100 (NCT05684705)BioVersys AG2023-09-01
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB (NCT05685615)BioVersys AG2023-04-20
To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100 (NCT05684718)BioVersys AG2023-02-01
A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment (NCT05537142)BioVersys AG2022-09-02
A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants (NCT05537090)BioVersys AG2022-09-01
Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis. (NCT05258877)BioVersys AG2022-06-10
Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment (NCT05086107)BioVersys AG2021-10-08
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BVL-GSK098 in Healthy Volunteers (NCT04654143)BioVersys AG2020-12-02

Track BioVersys AG automatically

Every clearance here is in the API, with alerts when new ones post.